The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canin...

Por M. R. Chambers, R. Timothy Bentley, David K. Crossman, Jeremy B. Foote, Jey W. Koehler, James M. Markert, Nidal B. Omar, Simon R. Platt, D. Mitchell Self, Andy Shores, Donald C. Sorjonen, Alicia M. Waters, Amy B. Yanke, G. Yancey Gillespie
Publicado em 2020-08-01